PHARMAGEST INTER. Stock Euronext Paris
Equities
FR0000077687
IT Services & Consulting
End-of-day quote
Other stock markets
|
||
- EUR | - |
Apr. 02 | Equasens : RNPG virtually stable in 2023 | CF |
Mar. 29 | Equasens Société Anonyme Provides Revenue Guidance for the 2025 | CI |
Sales 2023 | 220M 235M | Sales 2024 * | 231M 248M | Capitalization | 893M 955M |
---|---|---|---|---|---|
Net income 2023 | 47M 50.27M | Net income 2024 * | 49M 52.41M | EV / Sales 2023 | 4.18 x |
Net cash position 2023 * | 35.92M 38.43M | Net cash position 2024 * | 64.17M 68.64M | EV / Sales 2024 * | 3.58 x |
P/E ratio 2023 |
19.5
x | P/E ratio 2024 * |
17.8
x | Employees | - |
Yield 2023 * |
2.05% | Yield 2024 * |
2.24% | Free-Float | 32.43% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 90-12-31 | |
Thierry Chapusot
FOU | Founder | 65 | 96-01-24 |
Director of Finance/CFO | - | 22-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thierry Chapusot
FOU | Founder | 65 | 96-01-24 |
Director/Board Member | 46 | 17-06-26 | |
Director/Board Member | 59 | 99-12-31 |
1st Jan change | Capi. | |
---|---|---|
-10.65% | 199B | |
+0.99% | 168B | |
+12.56% | 167B | |
+5.85% | 101B | |
+6.27% | 78.31B | |
+16.57% | 72.48B | |
-7.27% | 71.7B | |
-22.12% | 50.48B | |
+0.90% | 48.34B |